Sruthi Sritharan - Publications

A recent decade update on combating doxorubicin-induced toxicities.

Journal: Archives of toxicology

Published: April 16, 2025

Epigenetic modulation of doxorubicin resistance and strategies for enhancing chemotherapeutic sensitivity.

Journal: International review of cell and molecular biology

Published: January 26, 2025

Secretion of IL-6 and TGF-β2 by Colon Cancer Cells May Promote Resistance to Chemotherapy.

Journal: Indian journal of clinical biochemistry : IJCB

Published: April 07, 2024

Doxorubicin-induced chemoresistance in Duke's type B colon adenocarcinoma cell line is aggravated in the presence of TGF-β2 through non-apoptotic cell death.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: September 28, 2023

Meta analysis of bioactive compounds, miRNA, siRNA and cell death regulators as sensitizers to doxorubicin induced chemoresistance.

Journal: Apoptosis : an international journal on programmed cell death

Published: May 30, 2022

A comprehensive review on time-tested anticancer drug doxorubicin.

Journal: Life sciences

Published: September 04, 2020

Curcumin induces chemosensitization to doxorubicin in Duke's type B coloadenocarcinoma cell line.

Journal: Molecular biology reports

Published: March 29, 2020

Curcumin induced apoptosis is mediated through oxidative stress in mutated p53 and wild type p53 colon adenocarcinoma cell lines.

Journal: Journal of biochemical and molecular toxicology

Published: March 10, 2020